MedMira, Inc. (MIR) | WebDisclosure

Basculer en Français

8295	Companies
114863	Keywords
55304	Articles
62446	Press releases

Home
Companies
MedMira, Inc.

BRIEF

published on 10/04/2024 at 01:05, 1 month 17 days ago

MedMira nomme un nouveau vice-président des opérations commerciales

Expansion En Amérique Du Nord MedMira Operations Commerciales Diagnostic Clinique Nicole Crenshaw
BRIEF

published on 10/04/2024 at 01:05, 1 month 17 days ago

MedMira Appoints New VP of Commercial Operations

North America Expansion MedMira Clinical Diagnostics Nicole Crenshaw Commercial Operations
PRESS RELEASE

published on 10/04/2024 at 01:00, 1 month 17 days ago

MedMira Announces the appointment of Vice President of Commercial Operations
MedMira Inc. appoints Nicole Crenshaw as VP of Commercial Operations to strengthen its leadership team and drive growth across commercial portfolio in North America

North American Expansion MedMira Inc. Vice President Nicole Crenshaw Commercial Operations
BRIEF

published on 08/13/2024 at 22:35, 3 months 7 days ago

Début des essais cliniques pour le test de dépistage de la syphilis Multiplo®

MedMira Inc. Essais Cliniques Santé Canada Test De Dépistage De La Syphilis Nexus REACH
BRIEF

published on 08/13/2024 at 22:35, 3 months 7 days ago

Clinical Trials Commence for Multiplo® Syphilis Test

Clinical Trials MedMira Inc. Health Canada Syphilis Test REACH Nexus
PRESS RELEASE

published on 08/13/2024 at 22:30, 3 months 7 days ago

Clinical Trials to get Underway with Multiplo(R) Complete Syphilis (TP/nTP) Antibody Test - A Potential Game Changer to Address Syphilis Health Crisis in Canada
MedMira Inc. announces full clinical trials for Multiplo® Complete Syphilis (TP/nTP) Antibody Test in Canada with REACH Nexus at MAP Centre for Urban Health Solutions. The innovative test combines screening and confirmation in under 3 minutes

Clinical Trials MedMira Inc. Syphilis REACH Nexus Multiplo® TP/nTP
BRIEF

published on 07/03/2024 at 05:05, 4 months 18 days ago

MedMira Reports Third Quarter Results FY2024

Financial Results MedMira Q3 FY2024 Reveal® G4 Distribution Partners
BRIEF

published on 07/03/2024 at 05:05, 4 months 18 days ago

MedMira publie ses résultats du troisième trimestre de l'exercice 2024

Résultats Financiers MedMira T3 De L'exercice 2024 Révéler® G4 Partenaires De Distribution
PRESS RELEASE

published on 07/03/2024 at 05:00, 4 months 18 days ago

MedMira Reports Third Quarter Results FY2024
MedMira Inc. reports Q3 FY2024 financial results including revenue, gross profit, operating expenses, net loss, and balance sheet highlights. Company focuses on US FDA approved HIV test and new clinical trials in Canada

Financial Results Clinical Trials MedMira Inc. Q3 FY2024 HIV Test
BRIEF

published on 05/01/2024 at 04:05, 6 months 20 days ago

MedMira nomme un nouveau vice-président du développement commercial

Stratégie De Croissance MedMira Développement Des Affaires Rene Bell Marché Américain De La Santé

1 2 ... 4

Accesswire

Published on 11/21/2024 at 12:00, 1 hour 6 minutes ago

Alset AI Announces Full Repayment of $3.7 Million Secured Loan with Interest from Portfolio Company, Significantly Strengthening Balance Sheet
Published on 11/21/2024 at 12:00, 1 hour 6 minutes ago

Battery X Metals Commences Strategic Initiatives to Strengthen Balance Sheet
Published on 11/21/2024 at 11:30, 1 hour 36 minutes ago

FireFox Trenching Returns More High-Grade Gold at the Mustajärvi Gold Project in Lapland, Finland
Published on 11/21/2024 at 10:03, 3 hours 3 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 3 hours 6 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 12:35, 31 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 51 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 59 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 1 hour 6 minutes ago

Holding(s) in Company
Published on 11/21/2024 at 11:30, 1 hour 36 minutes ago

APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived

Les Echos

Published on 11/21/2024 at 06:58, 6 hours 8 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 6 hours 8 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 6 hours 8 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 16 hours 58 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 17 hours 46 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE